#M2GENโs Dr. Michelle Churchman (@ml_churchman) joins Dr. Gudbjorg Jonsdottir (@gudbjorgjon) at #ASCO22 as she presents work from her #ORIEN Intermember project: โThe impact of HRD in patients with pancreatic adenocarcinoma who undergo surgical resection: an updated analysis.โ
Join #ORIEN member Dr. Gudbjorg Jonsdottir (@gudbjorgjon) as she presents research on pancreatic cancer treatments using ORIEN Avatar data at #ASCO22, this Sat. June 4 at 9 AM ET (Poster #118).
Read more about her presentation here: https://t.co/1EcrKJxp0i
The rising star in smoldering myeloma (SMM) @SigrunThorstei1 will present how common smoldering myeloma really is at 12 o'clock today!
Spoiler alert: It is more common than you think...
The @iStopMM team is so proud of her!
@sykristinsson@IMFmyeloma@TheBindingSite
We pride ourselves on the mentorship & guidance our senior residents provide to our program and team. Dr. Asgeir Masson and Dr. Kelsey Koch were nominated for two ACS Awards for their work in promoting important competencies in medicine. Congrats @KelseyKochMD & @asgeirthm #Iowa
@uihealthcare@gudbjorgjon @uni_iceland @IowaPSTP @UIowaCancer Worth noting that the last physician to earn a PhD from @uni_iceland while also in one of our training programs was then-PGY3 @AThorarinn in 2019.
Dr. Jonsdottir was there for his defense.
https://t.co/Pjb2n4PJ3n
Just a couple months before the end of her second year in our @uihealthcare#HemOncFellowship, now Chief Fellow @gudbjorgjon successfully defended her PhD dissertation at @uni_iceland. Well done! Cc: @IowaPSTP @UIowaCancer
https://t.co/MkxSo6IxRV
This just out from our group:
Based on >25,000 MM pts: Increased cumulative doses of alkylating therapy with melphalan increases the subsequent risk of developing AML/MDS in patients with MM #mmsm
https://t.co/ikfkmyysYR
@gudbjorgjon@DrOlaLandgren@MalinHultcrantz